| |
As a group, rhythm disturbances represent a significant class of cardiac indications with wide ranging morbidity and mortality implications. Treatment of arrhythmias that do not respond to medication is based on RF catheter ablation. In recent years, cardiac ablation procedures have become more clinician- and patient-friendly, as integrated cardiac mapping systems continue to evolve. These systems combine computerized mapping engines capable of imaging the anatomical geometries of the heart chambers and catheter positioning technology that enables precise catheter location.
The market and clinical potential of these systems is increasing as improvements in the underlying computational and rendering technology converge with enhancements to various system components to refine procedural performance and extend AF ablation to an expanding list of difficult to treat arrhythmias. These developments include the commercialization of a new generation of array or mesh mapping catheters, variable geometry catheters, and catheters that have been designed to optimize positioning performance with specific mapping engine architectures.
As the market develops, competition is intensifying among market sector participants and their underlying platform technologies. In this arena, magnetic navigation systems are being pursued by players with systems based on more traditional modalities such as ultrasound and visually guided systems.
More information on the clinical prospects and shifting market opportunities for cardiac mapping systems can be found in a comprehensive report, researched and prepared by Greystone Associates. Cardiac Mapping Systems: Evolving Technology, Expanding Opportunities analyzes the current market and demand factors driving the growth of cardiac mapping. The report examines key indications and market segments, technology factors, and the intricate competitive landscape.
About Greystone
Greystone Associates (greystoneassociates.org) is a medical technology consulting firm focused on the areas of medical market strategy, product commercialization, venture development, and market research. We assist medical and healthcare market participants in achieving their business objectives through the creation of detailed development strategies, product commercialization programs, and comprehensive market and technology research and analysis. Our market research publications are designed, researched and written to provide timely and insightful information and data on focused market segments, with the aim of providing market participants with the essential knowledge to refine and execute their marketing plans and financial targets.
|
mksmith[.]greystoneassociates.org 
